𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Zoledronic acid's survival benefit lasts in premenopausal patients

✍ Scribed by DIANA MAHONEY

Book ID
118628786
Publisher
Frontline Medical Communications, Inc.
Year
2011
Tongue
English
Weight
54 KB
Volume
8
Category
Article
ISSN
1548-5315

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The impact of zoledronic acid therapy in
The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
✍ Kostantinos Zarogoulidis; Eufimia Boutsikou; Pavlos Zarogoulidis; Ellada Elefthe πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 213 KB πŸ‘ 2 views

## Abstract Bone metastases occur in 20–40% of patients with lung cancer. Recent studies demonstrate a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors, which may influence the survival. Therefore, we examined the clinical impact of zoledronic acid (ZOL; Zometa